Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein
about
Charting a Path to Success in Virtual ScreeningHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.Suramin Inhibits Chikungunya Virus Entry and TransmissionPeptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1.CD81 as a tumor target.
P2860
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@ast
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@en
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@nl
type
label
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@ast
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@en
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@nl
prefLabel
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@ast
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@en
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@nl
P2093
P2860
P50
P1433
P1476
Identification of a novel drug ...... geting the HCV E2 glycoprotein
@en
P2093
Abdul Ghafoor Khan
Adam Zemla
Alexander L Perryman
Felipe Vences Catalan
Joel S Freundlich
Joseph Marcotrigiano
Jost Vielmetter
Laure Saas
Reem R Al Olaby
Rod Balhorn
P2860
P304
P356
10.1371/JOURNAL.PONE.0111333
P407
P577
2014-01-01T00:00:00Z